AstraZeneca Pharma India Limited — Important, 19-03-2025: Updates

The company has received a draft assessment order from the Income Tax Department regarding transfer pricing adjustments for the assessment year 2022-23. The proposed adjustment amounts to approximately Rs. 11.96 crores, excluding interest and penalties. The company plans to challenge this order by filing an appeal with the Dispute Resolution Panel. Currently, the overall financial implications of this dispute cannot be precisely determined until the final assessment order is issued. Investors should stay informed as the situation develops, as it may significantly impact financial outcomes.